Gary Fanjiang, MD, MBA, MS

Gary Fanjiang, MD, MBA, MS, is the vice president of global development at Amgen, where he leads research and development activities for the Biosimilars Business Unit. He oversees the nonclinical, clinical, and medical affairs activities across a portfolio of 10 molecules in various stages of development in multiple therapeutic areas and indications of use. He previously served as executive medical director of global development at Amgen. Prior to joining Amgen, he held multiple positions at Abbott over the course of 8 years, and he held the associate director of clinical research role at AstraZeneca. After graduating from Tufts University and completing his residency and fellowship, he served as a fellow of pediatric gastroenterology and nutrition at Massachusetts General Hospital.
As a company with a 4-decade legacy of delivering innovative biologics to patients, and an equally fervent commitment in biosimilars (3 approved and 2 launched in the United States, with many more in our pipeline), Amgen understands that patient, physician, pharmacist, and payer confidence in the regulatory approval process is a critical factor to the long-term success of the US marketplace with biosimilars. We strongly believe appropriate clinical testing must be included in the regulatory approval process for biosimilars.
Sep 25, 2019 @04:13 PM

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.